Hepatitis B and C in institutions for individuals with intellectual disability.

Feldman et al. (1999) looked at hepatitis B and C inside institutions for people with intellectual disability. They wrote a narrative review, not a new experiment. The goal was to see how common the viruses were and whether staff were protecting residents with vaccines.

The paper pulled together older studies and outbreak reports. It focused on large residential settings, not small group homes or family homes.

Hepatitis B showed up again and again in these settings. The virus spread through shared toothbrushes, razors, and sometimes medical equipment. Hepatitis C data were too thin to draw firm conclusions.

The review said universal hepatitis B vaccination should be routine for all residents and staff. Yet many places still skipped the shots.

Oeseburg et al. (2011) later counted chronic conditions in children with ID. Their big systematic review folds in the hepatitis risk A et al. flagged, treating it as one more health burden this group faces.

Dudley et al. (2019) and Titlestad et al. (2019) pick up the story twenty years on. Both papers say adults with ID remain nearly invisible in U.S. health surveillance. They call for standard IDD questions on national surveys so we can finally track who gets viruses—and who gets vaccines.

Matson et al. (2009) and Chiviacowsky et al. (2013) show the same pattern with tobacco: higher use, little data, few programs. Together these reviews paint one picture—people with ID carry extra health risks, but the system keeps forgetting to count or protect them.

If you work in a day program, school, or residential home, treat hepatitis B as an active threat, not history. Check vaccine records during intake. If shots are missing, partner with a local clinic to run a catch-up campaign. One quick injection now prevents liver disease—and outbreaks—later.